PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis

Publisher: John Wiley & Sons Inc

E-ISSN: 1476-5381|172|17|4277-4290

ISSN: 0007-1188

Source: BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.172, Iss.17, 2015-09, pp. : 4277-4290

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract